longer dual antiplatelet therapy beyond 9 months does not influence neointimal condition after second generation drug eluting stent implantation

Back

ESC Premium Access

longer dual antiplatelet therapy beyond 9 months does not influence neointimal condition after second generation drug eluting stent implantation

Session: Dual antiplatelet therapy: the long and the short of it!

Topic: Thrombosis and platelets

Speaker: Doctor Y. Goryo (Kurashiki, JP)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Yutaka Goryo

Kawasaki Medical School, Kurashiki (Japan)

0 follower

5 more presentations in this session

Clinical outcomes in patients with diabetes mellitus receiving dual antiplatelet therapy more than 12 months after second-generation drug eluting stent implantation

Speaker: Doctor S. Cho (Goyang, KR)

Access

Abstract

Slides

Longer-term oral antiplatelet use in stable post-MI patients: Insights from the TIGRIS study

Speaker: Doctor S. Goodman (Toronto, CA)

Access

Abstract

Duration of dual antiplatelet therapy in patients treated with second generation drug-eluting stents: a systematic review and meta-analysis

Speaker: Doctor M. Bianco (Orbassano, IT)

Access

Abstract

Slides

Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation in patients with or without diabetes: a patient-level meta-analysis of randomised trials

Speaker: Doctor G. Gargiulo (Napoly, IT)

Access

Abstract

Slides

Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies

Speaker: Doctor G. Ferrante (Milan, IT)

Access

Abstract

Slides

Access the full session

Dual antiplatelet therapy: the long and the short of it!

Speakers: Doctor Y. Goryo, Doctor S. Cho, Doctor S. Goodman, Doctor M. Bianco, Doctor G. Gargiulo...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources